1. Boon T, Coulie P, Marchand M, Weynants P, Wolfel P, Brichard. V. Genes coding for tumor rejection agents: perspectives for specific immunotherapy. In: DeVita VT, Hellman S, Rosenberg SA, eds. Biologic therapy of cancer updates. Philadelphia: JB Lippincott, 1994;14:2.
2. Morgan DA, Ruscetti FW, Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 1976;193:1007.
3. Ruscetti FW, Morgan DA, Gallo RC. Functional and morphologic characterization of human T cells continuously grown in vitro. J Immunol 1977;119:131.
4. Linsley PS, Clark EA, Ledbetter JA. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990;238:75.
5. Cheever MA, Greenberg PD, Fefer A, et al. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured lymphocytes by in vivo administration of purified interleukin 2. j Exp Med 1982;155:968.